Health insurance coverage for hair loss treatments has become a prominent topic in Korea’s healthcare debate, moving from a personal issue to a matter considered within national policy. President Lee Jae Myung recently emphasized that hair loss is not just a cosmetic concern, calling it a survival issue. This marks a shift toward recognizing hair loss as a widespread health challenge that affects millions and should be managed at a national level.
Recent data from the National Health Insurance Service and the Health Insurance Review and Assessment Service reveal a growing number of people seeking medical help for hair loss, with 248,000 patients recorded in 2022. Yet, many more individuals are believed to suffer in silence, with estimates suggesting around 10 million Koreans experience some degree of hair loss. This large number underscores the importance of addressing hair loss as a public health priority.
The Korean Dermatological Association recommends that before any insurance reimbursement is allowed, specific medical principles must be followed. Hair loss covers various conditions, such as alopecia areata and androgenetic alopecia, each with different causes and treatments. Accurate diagnosis is crucial, and standardized systems like the Hamilton-Norwood or Korean BASP classification can help determine which patients truly need medical intervention. Coverage should be restricted to those who meet established severity levels, ensuring that limited insurance funds are used efficiently.
Professional evaluation is another important factor. Since hair loss can be a symptom of other diseases, reimbursement based only on medication without specialist assessment could miss underlying health problems. The Association stresses the need for dermatologist-led diagnosis and consultations to be part of any coverage plan.
Additionally, managing hair loss requires a careful approach to long-term costs. Since hair loss is a chronic condition, expanding insurance coverage without strict management controls could threaten the financial stability of the health insurance system. There must be clear guidelines for treatment and evidence-based criteria to protect resources and ensure sustainability. Equity is also an issue, as nearly half of affected patients are women, yet treatment coverage is less developed for them. Addressing these gaps and building clinical evidence for female treatments is necessary for fair policy outcomes. The Korean Dermatological Association continues to work with the government to develop a rational, sustainable framework that will meet the needs of all hair loss patients without compromising the health insurance system.
